We are live on ! Find out more
MO

McMillan Office Portfolio holdings

AUM $871M
This Fund
S&P 500
This Quarter Est. Return
+15.13%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$871M
AUM Growth
+$89.2M
Cap. Flow
-$5.22M
Cap. Flow %
-0.6%
Top 10 Hldgs %
58.63%
Holding
512
New
12
Increased
19
Reduced
51
Closed
5
Avg Time Held
1.9 quarters
Top 10 Avg Time Held
1.6 quarters
Top 20 Avg Time Held
1.9 quarters

Top Sells

Rank Stock Value
1
HON icon
Honeywell
HON
+$728K
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$727K
3
QQQ icon
Invesco QQQ Trust
QQQ
+$422K
4
AAPL icon
Apple
AAPL
+$354K
5
ALB icon
Albemarle
ALB
+$265K

Sector Composition

Rank Sector Weight
1 Communication Services 25.91%
2 Technology 22.47%
3 Financials 10.87%
4 Miscellaneous 9.68%
5 Healthcare 9.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
CI icon
126
Cigna
CI
$74.6B
$486K 0.06%
1,762
– –
2025 Q4
2 quarters
IWM icon
127
iShares Russell 2000 ETF
IWM
$77.4B
$481K 0.06%
1,600
– –
2025 Q4
2 quarters
MDY icon
128
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$25.7B
$471K 0.05%
670
– –
2025 Q4
2 quarters
BDX icon
129
Becton Dickinson
BDX
$50.1B
$470K 0.05%
3,105
– –
2025 Q4
2 quarters
BX icon
130
Blackstone
BX
$85.8B
$459K 0.05%
3,900
– –
2025 Q4
2 quarters
ORCL icon
131
Oracle
ORCL
$429B
$454K 0.05%
3,100
– –
2025 Q4
2 quarters
VGSH icon
132
Vanguard Short-Term Treasury ETF
VGSH
$34.5B
$448K 0.05%
7,700
– –
2025 Q4
2 quarters
MPC icon
133
Marathon Petroleum
MPC
$128B
$447K 0.05%
1,750
– –
2025 Q4
2 quarters
TEVA icon
134
Teva Pharmaceutical Industries Limited
TEVA
$47.9B
$429K 0.05%
12,675
– –
2025 Q4
2 quarters
STT icon
135
State Street
STT
$48.1B
$424K 0.05%
2,500
– –
2025 Q4
2 quarters
PNC icon
136
PNC Financial Services
PNC
$87.5B
$420K 0.05%
1,707
– –
2025 Q4
2 quarters
UNH icon
137
UnitedHealth
UNH
$340B
$416K 0.05%
1,000
– –
2025 Q4
2 quarters
FBIN icon
138
Fortune Brands Innovations
FBIN
$4.66B
$402K 0.05%
7,329
– –
2025 Q4
2 quarters
ENB icon
139
Enbridge
ENB
$104B
$390K 0.04%
7,194
– –
2025 Q4
2 quarters
GSK icon
140
GSK
GSK
$93.2B
$380K 0.04%
7,241
– –
2025 Q4
2 quarters
PINS icon
141
Pinterest
PINS
$12.1B
$348K 0.04%
16,530
-220
-1% -$4.42K
2025 Q4
2 quarters
BOX icon
142
Box
BOX
$4.99B
$345K 0.04%
12,990
– –
2025 Q4
2 quarters
NFLX icon
143
Netflix
NFLX
$293B
$330K 0.04%
4,626
+713
+18% +$62.8K
2025 Q4
2 quarters
WFC icon
144
Wells Fargo
WFC
$253B
$329K 0.04%
3,978
– –
2025 Q4
2 quarters
MA icon
145
Mastercard
MA
$516B
$326K 0.04%
635
– –
2025 Q4
2 quarters
WSBC icon
146
WesBanco
WSBC
$3.51B
$322K 0.04%
8,250
– –
2025 Q4
2 quarters
GILD icon
147
Gilead Sciences
GILD
$187B
$321K 0.04%
2,540
– –
2025 Q4
2 quarters
BA icon
148
Boeing
BA
$150B
$320K 0.04%
1,476
– –
2025 Q4
2 quarters
CRWV
149
CoreWeave
CRWV
$45.3B
$309K 0.04%
3,100
– –
2025 Q4
2 quarters
SCHW
150
Charles Schwab
SCHW
$167B
$304K 0.04%
3,300
– –
2025 Q4
2 quarters

Similar funds

McMillan Office's Q2 2026 Portfolio in Review

As of Q2 2026, McMillan Office held 512 positions worth $871M, up 11% from $782M the previous quarter. Its ten largest holdings account for 59% of the portfolio.

Trading was light in Q2 2026: portfolio turnover was 3.3%. McMillan Office opened 12 new positions and exited 5, leaving the 512-position portfolio largely intact.

By sector, the portfolio is most concentrated in Communication Services at 26% of assets, up from 25% a quarter earlier, followed by Technology and Financials.

  • McMillan Office's largest Q2 2026 buy was Honeywell Aerospace: 3,259 shares worth $721K.
  • McMillan Office added most to Microsoft in Q2 2026, an estimated $386K increase.
  • McMillan Office's biggest Q2 2026 reduction was Honeywell, cutting an estimated $728K.
  • McMillan Office fully exited TopBuild in Q2 2026, selling an estimated $54.1K.
  • McMillan Office's ten largest holdings make up 59% of its $871M portfolio in Q2 2026.
  • McMillan Office opened 12 new positions and closed 5 in Q2 2026.
  • McMillan Office's portfolio value rose 11% quarter-over-quarter to $871M.

Based on McMillan Office's 13F filing for Q2 2026, filed 13 Aug 2026.